124 related articles for article (PubMed ID: 9222050)
1. Concentrations of trovafloxacin in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum after administration of single or multiple oral doses to patients undergoing fibre-optic bronchoscopy.
Andrews JM; Honeybourne D; Brenwald NP; Bannerjee D; Iredale M; Cunningham B; Wise R
J Antimicrob Chemother; 1997 Jun; 39(6):797-802. PubMed ID: 9222050
[TBL] [Abstract][Full Text] [Related]
2. Concentrations of moxifloxacin in serum and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.
Soman A; Honeybourne D; Andrews J; Jevons G; Wise R
J Antimicrob Chemother; 1999 Dec; 44(6):835-8. PubMed ID: 10590288
[TBL] [Abstract][Full Text] [Related]
3. The concentrations of clinafloxacin in alveolar macrophages, epithelial lining fluid, bronchial mucosa and serum after administration of single 200 mg oral doses to patients undergoing fibre-optic bronchoscopy.
Honeybourne D; Andrews JM; Cunningham B; Jevons G; Wise R
J Antimicrob Chemother; 1999 Jan; 43(1):153-5. PubMed ID: 10381116
[TBL] [Abstract][Full Text] [Related]
4. Concentrations of levofloxacin (HR 355) in the respiratory tract following a single oral dose in patients undergoing fibre-optic bronchoscopy.
Andrews JM; Honeybourne D; Jevons G; Brenwald NP; Cunningham B; Wise R
J Antimicrob Chemother; 1997 Oct; 40(4):573-7. PubMed ID: 9372428
[TBL] [Abstract][Full Text] [Related]
5. Concentrations of gatifloxacin in plasma and pulmonary compartments following a single 400 mg oral dose in patients undergoing fibre-optic bronchoscopy.
Honeybourne D; Banerjee D; Andrews J; Wise R
J Antimicrob Chemother; 2001 Jul; 48(1):63-6. PubMed ID: 11418513
[TBL] [Abstract][Full Text] [Related]
6. Lung concentrations of telithromycin after oral dosing.
Khair OA; Andrews JM; Honeybourne D; Jevons G; Vacheron F; Wise R
J Antimicrob Chemother; 2001 Jun; 47(6):837-40. PubMed ID: 11389116
[TBL] [Abstract][Full Text] [Related]
7. The penetration of rufloxacin into sites of potential infection in the respiratory tract.
Wise R; Andrews J; Imbimbo BP; Greaves I; Honeybourne D
J Antimicrob Chemother; 1993 Dec; 32(6):861-6. PubMed ID: 8144426
[TBL] [Abstract][Full Text] [Related]
8. The distribution of temafloxacin in bronchial epithelial lining fluid, alveolar macrophages and bronchial mucosa.
Baldwin DR; Wise R; Andrews JM; Ashby JP; Honeybourne D
Eur Respir J; 1992 Apr; 5(4):471-6. PubMed ID: 1314193
[TBL] [Abstract][Full Text] [Related]
9. Concentrations of garenoxacin in plasma, bronchial mucosa, alveolar macrophages and epithelial lining fluid following a single oral 600 mg dose in healthy adult subjects.
Andrews J; Honeybourne D; Jevons G; Boyce M; Wise R; Bello A; Gajjar D
J Antimicrob Chemother; 2003 Mar; 51(3):727-30. PubMed ID: 12615879
[TBL] [Abstract][Full Text] [Related]
10. Rifampicin concentrations in bronchial mucosa, epithelial lining fluid, alveolar macrophages and serum following a single 600 mg oral dose in patients undergoing fibre-optic bronchoscopy.
Ziglam HM; Baldwin DR; Daniels I; Andrew JM; Finch RG
J Antimicrob Chemother; 2002 Dec; 50(6):1011-5. PubMed ID: 12461025
[TBL] [Abstract][Full Text] [Related]
11. Concentrations in plasma, epithelial lining fluid, alveolar macrophages and bronchial mucosa after a single intravenous dose of 1.6 mg/kg of iclaprim (AR-100) in healthy men.
Andrews J; Honeybourne D; Ashby J; Jevons G; Fraise A; Fry P; Warrington S; Hawser S; Wise R
J Antimicrob Chemother; 2007 Sep; 60(3):677-80. PubMed ID: 17623694
[TBL] [Abstract][Full Text] [Related]
12. Hepatobiliary elimination of trovafloxacin and metabolites following single oral doses in healthy volunteers.
Melnik G; Schwesinger WH; Teng R; Dogolo LC; Vincent J
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):424-6. PubMed ID: 9758286
[TBL] [Abstract][Full Text] [Related]
13. Comparative penetration of selected fluoroquinolones into respiratory tract fluids and tissues.
Wise R
Am J Med; 1991 Dec; 91(6A):67S-70S. PubMed ID: 1662897
[TBL] [Abstract][Full Text] [Related]
14. Single- and multiple-dose administration, dosing regimens, and pharmacokinetics of trovafloxacin and alatrofloxacin in humans.
Vincent J; Dogolo L; Baris BA; Willavize SA; Teng R
Eur J Clin Microbiol Infect Dis; 1998 Jun; 17(6):427-30. PubMed ID: 9758287
[TBL] [Abstract][Full Text] [Related]
15. Concentrations of OPC-17116, a new fluoroquinolone antibacterial, in serum and lung compartments.
Cook PJ; Andrews JM; Wise R; Honeybourne D; Moudgil H
J Antimicrob Chemother; 1995 Feb; 35(2):317-26. PubMed ID: 7759395
[TBL] [Abstract][Full Text] [Related]
16. Penetration of sparfloxacin and ciprofloxacin into alveolar macrophages, epithelial lining fluid, and polymorphonuclear leucocytes.
Schüler P; Zemper K; Borner K; Koeppe P; Schaberg T; Lode H
Eur Respir J; 1997 May; 10(5):1130-6. PubMed ID: 9163658
[TBL] [Abstract][Full Text] [Related]
17. Comparative bronchoalveolar concentrations of ciprofloxacin and lomefloxacin following oral administration.
Baldwin DR; Wise R; Andrews JM; Gill M; Honeybourne D
Respir Med; 1993 Nov; 87(8):595-601. PubMed ID: 8290743
[TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and metabolism of single oral doses of trovafloxacin.
Vincent J; Teng R; Dalvie DK; Friedman HL
Am J Surg; 1998 Dec; 176(6A Suppl):8S-13S. PubMed ID: 9935250
[TBL] [Abstract][Full Text] [Related]
19. Oral bioavailability of trovafloxacin with and without food in healthy volunteers.
Teng R; Dogolo LC; Willavize SA; Friedman HL; Vincent J
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():87-92. PubMed ID: 9222076
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics and safety of trovafloxacin in healthy male volunteers following administration of single intravenous doses of the prodrug, alatrofloxacin.
Vincent J; Venitz J; Teng R; Baris BA; Willavize SA; Polzer RJ; Friedman HL
J Antimicrob Chemother; 1997 Jun; 39 Suppl B():75-80. PubMed ID: 9222074
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
